Home > Financial Ratios > MEDICO REMEDIES

MEDICO REMEDIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for MEDICO REMEDIES
Please provide your vote to see the results

MEDICO REMEDIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 8.916.756.064.283.21

What is the latest Core EBITDA Margin ratio of MEDICO REMEDIES ?

The latest Core EBITDA Margin ratio of MEDICO REMEDIES is 8.91 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20248.91
Mar20236.75
Mar20226.06
Mar20214.28
Mar20203.21

How is Core EBITDA Margin of MEDICO REMEDIES Trending?

Years Core EBITDA Margin % Change
Mar2024 8.91
32.00
Mar2023 6.75
11.39
Mar2022 6.06
41.59
Mar2021 4.28
33.33
Mar2020 3.21 -

Other Financial Ratios of MEDICO REMEDIES


Compare Core EBITDA Margin ratio of peers of MEDICO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICO REMEDIES ₹381.9 Cr 3% -5.9% -41.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr -1.6% -6% 46.1% Stock Analytics
DIVIS LABORATORIES ₹159,306.0 Cr 0.4% 3.9% 64% Stock Analytics
CIPLA ₹120,459.0 Cr 1.8% 0.2% 17.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,168.0 Cr 0.5% -7.9% 6.7% Stock Analytics
ZYDUS LIFESCIENCES ₹95,662.7 Cr 0.7% -4% 48.3% Stock Analytics


MEDICO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICO REMEDIES

3%

-5.9%

-41.7%

SENSEX

3.4%

0.2%

21.7%


You may also like the below Video Courses